Related Experiment Video
Updated: May 5, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Inflammation, Endothelial Dysfunction, and Platelet Dysregulation in Atrial Fibrillation with Chronic Kidney Disease:
Maria-Daniela Tanasescu1, Andrei-Mihnea Rosu2, Alexandru Minca1
1Department of Semiology-Emergency University Hospital, Carol Davila University of Medicine and Pharmacy, 022328 Bucharest, Romania.
Insights
Patients with atrial fibrillation (AF) and chronic kidney disease (CKD) face high risks of stroke and bleeding. Current treatments inadequately address shared biological pathways, necessitating a biology-informed approach to anticoagulation.
Area of Science:
- Cardiology
- Nephrology
- Vascular Biology
Background:
- Atrial fibrillation (AF) and chronic kidney disease (CKD) commonly coexist, increasing risks of thromboembolic and bleeding events.
- Current anticoagulation dosing based on creatinine clearance may not fully address the complex pathophysiology of thrombohemorrhagic instability in this population.
Purpose of the Study:
- To review recent evidence on the bidirectional cardio-renal axis in AF and CKD.
- To focus on shared pathophysiological mechanisms including inflammation, endothelial dysfunction, and platelet dysregulation.
- To propose a shift towards a biology-informed anticoagulation strategy.
Main Methods:
- A narrative review synthesizing mechanistic and translational evidence.
- Structured literature search of PubMed/MEDLINE, Scopus, and Web of Science (2018-2026).
- Manual review of key references and guidelines.
Main Results:
- Shared mechanisms in AF and CKD include inflammatory cytokine activation, oxidative stress, glycocalyx degradation, and platelet dysfunction.
- These factors create a disrupted vascular interface leading to both stroke and bleeding.
- Renal trajectory and biomarkers indicate dynamic and heterogeneous risk in advanced CKD.
Conclusions:
- Anticoagulation decisions in AF with CKD should move beyond static filtration models.
- A biology-informed approach integrating renal dynamics, vascular phenotype, and clinical context is needed.
- This approach aims to optimize the balance between thromboembolic protection and bleeding safety.
Abstract:
Atrial fibrillation (AF) frequently coexists with chronic kidney disease (CKD), and their combination confers a disproportionate risk of both thromboembolic and bleeding events. Conventional anticoagulation strategies rely primarily on creatinine clearance-based dosing, which reflects pharmacokinetic safety but does not fully capture the biological processes underlying thrombohemorrhagic instability. This narrative review synthesizes recent mechanistic and translational evidence regarding the bidirectional cardio-renal axis in AF and CKD, focusing on systemic inflammation, endothelial dysfunction, platelet dysregulation, and altered coagulation. A structured literature search of PubMed/MEDLINE, Scopus, and Web of Science (2018-2026) was performed, complemented by manual review of key references and guidelines. The evidence indicates that inflammatory cytokine activation, oxidative stress, glycocalyx degradation, von Willebrand factor dysregulation, uremic platelet dysfunction, and enhanced thrombin generation converge to create a disrupted vascular interface in which stroke and bleeding arise from shared pathophysiological mechanisms. Renal trajectory and selected circulating biomarkers further highlight the dynamic and heterogeneous nature of risk in advanced CKD. These findings support reframing anticoagulation decision-making in AF with CKD from a static filtration-based model toward a biology-informed approach that integrates renal dynamics, endothelial and platelet phenotype, and clinical context to better align thromboembolic protection with hemorrhagic safety.
Related Concept Videos
Chronic Kidney Disease III: Interprofessional Care
Acute Kidney Injury II: Pathophysiology
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease II: Clinical Manifestations
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Acute Kidney Injury IV: Diagnostic Studies and Prevention

